SEC Form 4 · accession 0001209191-16-122630
Epizyme, Inc. · EPZM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew R Allen
Director
Period of report
May 19, 2016
Accepted (ET)
May 23, 2016 · 4:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001571498
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $9.33 | May 19, 2016 | A | 12,500 | A | — | May 18, 2026 | Common Stock | 12,500 | 12,500 | D |
Explanation of responses
- F1This option was granted on May 19, 2016, pursuant to the Company's 2013 Stock Incentive Plan with respect to 12,500 shares of Common Stock and vests in full on May 19, 2017 and, in the event of a change in control of the Company, the vesting will accelerate in full.